Paras Healthcare Limited IPO
What the filing actually says
Our read of the offer document and the exchange data — not the issuer's summary of itself
Dates
The issuer's tentative timetable — a date passing is not confirmation the step completed
- Opens21 Oct 2026
- Closes23 Oct 2026
- Allotment26 Oct 2026
- Listing28 Oct 2026
Grey market premium
Unofficial dealer quotes — not published by NSE, BSE, SEBI or the company
What this number is not. Grey-market premium is an unregulated, thinly-traded quote from private dealers. It is not a forecast of the listing price, it is not verifiable, and it can be moved by the same people who benefit from it looking high. We publish it because you will look it up anyway — and we deliberately do not convert it into an expected listing gain, because that arithmetic implies a reliability the number has never earned. For what actually happened to comparable issues, see recent outcomes below.
The offering
Terms, structure and who is selling
What happened to comparable issues
The last 8 issues to list with a recorded opening price, most comparable first
Past issues are context, not a forecast — this issue is a different company at a different price. We show it because "how have issues like this one actually opened" is a question with a real answer, and grey-market premium is not that answer.
About Paras Healthcare Limited
Paras Healthcare is a hospital operator providing tertiary and quaternary healthcare services through a network of eight hospitals under the Paras Health brand. As of June 30, 2026, the company was present in five states and one Union Territory. Its hospitals are located in Gurugram and Panchkula in Haryana, Patna and Darbhanga in Bihar, Kanpur in Uttar Pradesh, Udaipur in Rajasthan, Ranchi in Jharkhand, and Srinagar in Jammu and Kashmir. The company provides treatments across several clinical specialities, including cardiac sciences, oncology sciences, neurosciences, gastro sciences, orthopaedics and sports injury, and renal sciences. As of June 30, 2026, its hospital network had 1,084 doctors and 1,937 nurses. Use of proceeds: The IPO consists of both a fresh issue of shares and an offer for sale (OFS). Proceeds from the OFS will go to the respective selling shareholders, whereas the net proceeds from the fresh issue will be utilised for the following purposes: Prepayment or scheduled repayment, in full or part, of certain outstanding borrowings availed by the company — Rs 320.90 crore Investment in the wholly owned subsidiary, PMHPL, for repayment/prepayment of borrowings, in full or part, of PMHPL — Rs 54.10 crore General corporate purposes
Offer documents
The primary sources everything above is drawn from
Common questions
What is the Paras Healthcare Limited IPO GMP today?
The most recent grey-market premium recorded for Paras Healthcare Limited is ₹96 per share — about 13.9% over the ₹693 upper band. Grey-market premium is an unofficial, unregulated quote from private dealers. It is not published by NSE, BSE, SEBI or the company, and it is not a forecast of the listing price.
What is the minimum investment in the Paras Healthcare Limited IPO?
One lot is 21 shares, so a retail application at the ₹693 cut-off price blocks ₹14,553. Retail applications are capped at ₹2,00,000; above that you bid in the HNI category, where allotment is proportionate rather than by lottery.
When is the Paras Healthcare Limited IPO allotment date?
Allotment is scheduled for 2026-10-26, with listing on 2026-10-28. These dates are the issuer's tentative timetable — a date passing is not confirmation that the step completed. Allotment status is published by the registrar, MUFG Intime India Pvt Ltd.
Disclaimer. Figures are compiled from the issuer's offer document and exchange-published bidding data. Subscription changes until the issue closes, and the final basis of allotment is published by the registrar. Grey-market premium is unofficial and is not a forecast. Nothing here is investment advice or a recommendation — read the offer document and consult a SEBI-registered adviser before applying.